2-es típusú cukorbetegség: vizsgálatok itt: Kazahsztán
4 of 7 trials · From ClinicalTrials.gov, checked 2026. november 19.. Ask the study team whether a trial fits you.
- No phaseTaking peopleiCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases
- Where
- Aktobe, Almaty
- Életkor
- 18 év and over
- People
- 35 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT03549754 - No phaseTaking peopleAssessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes
- Where
- Aktobe
- Életkor
- 18 év to 74 év
- People
- 310
- Run by
- West Kazakhstan Marat Ospanov Medical University
See details and how to joinNCT07512934 - No phaseTaking peopleEpigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
- Where
- Almaty
- Életkor
- 18 év to 69 év
- People
- 6720
- Run by
- Asfendiyarov Kazakh National Medical University
See details and how to joinNCT06953180 - No phaseCsak meghívásosStudy of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population
- Where
- Astana
- Életkor
- 18 év to 65 év
- People
- 100
- Run by
- Astana Medical University
See details and how to joinNCT07038213